Data are n (%) or means SD. The abdominally obese subjects were randomised after 2 months of VLED (from month 2 to month 0) to receive either orlistat (O)
or placebo (P). Values at the various times are absolute changes from initial values (month 2) calculated from the intention-to-treat population. Minus indicates
reduction from initial values and plus increment. Body weight changes are also given in percentage (in parentheses). P values are given for the absolute changes after
36 months between orlistat and placebo. The time effect at 36 months versus 0 month is significant for all parameters (P 0.001).